Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1283658-71-8
1621616-14-5
1807503-87-2
1807521-04-5
2055042-62-9
1919044-99-7
1251022-31-7 | Racemic-(3aR,4S,6S,7S,7aS)-5-(tert-butoxycarbonyl)-2,2-dimethylhexahydro-4,7-methano[1,3]dioxolo[4,5-c]pyridine-6-carboxylic acid | AA019EIH | MFCD22370082
1401464-08-1 | 2-((1R,5S,6s)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexan-6-yl)acetic acid | AA019ELM | MFCD12198681
2013-90-3 | 3-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid | AA019EOF | MFCD20638490
546107-39-5 | 1-(4-ethylpiperazin-1-yl)-2-(4-nitrophenyl)ethanone | AA019ERU | MFCD03396102
254744-55-3 | 3-(4-Bromo-3-[1,3]dioxolan-2-yl-benzyl)-2-butyl-1,3-diaza-spiro[4.4]non-1-en-4-one | AA019EV8 | MFCD20270118
1771023-28-9 | 4-bromo-2-fluoro-N-(4-iodophenyl)-benzenesulfonamide | AA019EXY | MFCD31652798
942918-07-2 | GSK-1070916 | AA019FR3 | MFCD22420815
1023814-92-7 | 6-Oxospiro[3.3]heptane-2,2-dicarboxylic acid | AA019G3Y | MFCD09754283
438021-88-6 | 3-[(3-chlorophenyl)sulfamoyl]-4-methylbenzoic acid | AA019GIR | MFCD02712878
568544-06-9 | 2-(1H-1,3-benzodiazol-2-yl)-1-(4-methylphenyl)ethan-1-one | AA019GT2 | MFCD03965294